Cargando…
Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment
Since the outbreak of corona virus disease 2019 (COVID-19) in Wuhan (China) in December 2019, the epidemic has rapidly spread to many countries around the world, posing a huge threat to global public health. In response to the pandemic, a number of clinical studies have been initiated to evaluate th...
Autores principales: | Zou, Houwen, Yang, Yuqi, Dai, Huiqiang, Xiong, Yunchuang, Wang, Jing-Quan, Lin, Lusheng, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646041/ https://www.ncbi.nlm.nih.gov/pubmed/34880750 http://dx.doi.org/10.3389/fphar.2021.732403 |
Ejemplares similares
-
Interaction between Chinese medicine and digoxin: Clinical and research update
por: Zhuang, Wei, et al.
Publicado: (2023) -
OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance
por: Yang, Yuqi, et al.
Publicado: (2021) -
Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
por: Zhang, Jingyao, et al.
Publicado: (2018) -
Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021) -
Editorial: Brief research reports in experimental pharmacology and drug discovery: 2022
por: Hassan, Tahsin, et al.
Publicado: (2023)